Comments Thread For: WBC Prez: I'm Not Protecting Canelo, But We Have To Be Fair!
Collapse
-
-
-
Comment
-
Is clen illegal for its benefits or is it illegal because it's a masking agent??Comment
-
For those that want proof:
Written by Dr Ha Machiels (pulmonogolist) and Prof Dekhuijizen (specializes in inhalation technology and sports medicine), their study is called "Athletes and doping: effects of drugs on the respiratory system".
".....When administered orally or parenterally clenbuterol has a special position within the group of β2 adrenoceptor agonists, having the most prominent anabolic effect, being lipophilic, and having a long duration of action (30–35 hours in humans)"
"....Several studies have reported that increased muscle growth was accompanied by an increase in protein and RNA content and increased protein synthesis (indicated by an increased RNArotein ratio)"
"... it appears that clenbuterol has anti-catabolic effects resulting in skeletal muscle hypertrophy. In addition, a shift towards fast twitch skeletal muscle fibres has been observed, facilitating heavy and rapid contractions (like weight lifting)"
And from the British journal of pharmacology: "....The anabolic effects of oral β2-AR agonists have been well documented (Zeman et al., 1988; Moore et al., 1994; Ryall et al., 2006) and are associated with an increase in skeletal muscle protein, largely due to the inhibition of protein degradation (Reeds et al., 1986; Yang and McElligott, 1989; Maltin et al., 1993). In addition to the increase in muscle mass, β2-AR agonists also decrease body fat (Yang and McElligott, 1989), hence their classification as ‘repartitioning agents'. The increase in muscle mass is associated with an increase in muscle force production (Zeman et al., 1988; Dodd et al., 1996). The β2-AR agonist-induced skeletal muscle hypertrophy is evident in fast- (Type II) and slow- (Type I) twitch muscles (Zeman et al., 1988; Dodd et al., 1996), although in some muscles a change in the proportion of fast- to slow-twitch fibres may occur (Zeman et al., 1988; Baker et al., 2006; Burniston et al., 2007"
So the evidence is certainly there - amongst a plethora of sources, studies, and professionsLast edited by Street15; 03-19-2018, 12:06 PM.Comment
-
Im not defending anyone. I just want to wait and hear more.... I want Pednelo to provide receipts, locations, etc. Something to help or hurt his testimony. Who said hes not gonna get suspended??? The NAC wanted to give Diaz a lifetime ban for WEED!!!Comment
-
For those that want proof:
Written by Dr Ha Machiels (pulmonogolist) and Prof Dekhuijizen (specializes in inhalation technology and sports medicine), their study is called "Athletes and doping: effects of drugs on the respiratory system".
".....When administered orally or parenterally clenbuterol has a special position within the group of β2 adrenoceptor agonists, having the most prominent anabolic effect, being lipophilic, and having a long duration of action (30–35 hours in humans)"
"....Several studies have reported that increased muscle growth was accompanied by an increase in protein and RNA content and increased protein synthesis (indicated by an increased RNArotein ratio)"
"... it appears that clenbuterol has anti-catabolic effects resulting in skeletal muscle hypertrophy. In addition, a shift towards fast twitch skeletal muscle fibres has been observed, facilitating heavy and rapid contractions (like weight lifting)"
And from the British journal of pharmacology: "....The anabolic effects of oral β2-AR agonists have been well documented (Zeman et al., 1988; Moore et al., 1994; Ryall et al., 2006) and are associated with an increase in skeletal muscle protein, largely due to the inhibition of protein degradation (Reeds et al., 1986; Yang and McElligott, 1989; Maltin et al., 1993). In addition to the increase in muscle mass, β2-AR agonists also decrease body fat (Yang and McElligott, 1989), hence their classification as ‘repartitioning agents'. The increase in muscle mass is associated with an increase in muscle force production (Zeman et al., 1988; Dodd et al., 1996). The β2-AR agonist-induced skeletal muscle hypertrophy is evident in fast- (Type II) and slow- (Type I) twitch muscles (Zeman et al., 1988; Dodd et al., 1996), although in some muscles a change in the proportion of fast- to slow-twitch fibres may occur (Zeman et al., 1988; Baker et al., 2006; Burniston et al., 2007"
So the evidence is certainly there - amongst a plethora of sources, studies, and professionsComment
-
Comment
-
Comment
Comment